The Discounted Cash Flow (DCF) valuation of Amedisys Inc (AMED) is 68.38 USD. With the latest stock price at 96.50 USD, the upside of Amedisys Inc based on DCF is -29.1%.
Based on the latest price of 96.50 USD and our DCF valuation, Amedisys Inc (AMED) is a sell. selling Amedisys stocks now will result in a potential gain of 29.1%.
| Range | Selected | |
| WACC / Discount Rate | 7.2% - 10.2% | 8.7% |
| Long-term Growth Rate | 1.0% - 3.0% | 2.0% |
| Fair Price | 50.29 - 107.62 | 68.38 |
| Upside | -47.9% - 11.5% | -29.1% |